Single cell mass spectrometry applied for multiparametric immune phenotyping with therapeutic implications in chronic lymphocytic leukemia (CLL)

Project: Research

Status	Finished
Effective start/end date	24/05/19 → 24/05/21

B-cell-specific IRF4 deletion accelerates chronic lymphocytic leukemia development by enhanced tumor immune evasion.
Asslaber, D. (First author), Qi, Y., Maeding, N., Steiner, M. (Co-author), Denk, U. (Co-author), Höpner, J. P., Hartmann, T. (Co-author), Zaborsky, N. (Co-author), Greil, R. (Co-author) & Egle, A. (Last author), 2019, In: BLOOD . 134, 20, p. 1729
Research output: Contribution to journal › Original Article › peer-review

21 Citations (Web of Science)

Project Details